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Abstract
Background and objectives: In our study we aimed to investigate the effect of esmolol, lidocaine 
and fentanyl on P-wave dispersion (Pwd), QT and corrected QT (QTc) durations and hemodynamic 
responses to endotracheal intubation during propofol induction. 
Methods: A total of eighty adult patients, American Society of Anesthesiologists (ASA) Physical 
Status I or II aged 18 to 60 years were included in this prospective, randomised, double-blind 
study. All patients had control electrocardiograms (ECGs) done before anesthesia induction. The 
patients were randomised into four equal groups. The control group (Group C) received saline 
5 mL, the esmolol group (Group E) received esmolol 0.5 mg.kg-1, the fentanyl group (Group F) 
received fentanyl 2 μg.kg-1 and the lidocaine group (Group L) received lidocaine 1.5 mg.kg-1 before 
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Introduction
Anesthetic agents may display proarrhythmic and antiarrhyth-
mic activity by inducing electrical activity through various 
mechanisms 1. Other than the anesthetic agents used, exis-
ting heart disease and other concomitant systemic diseases, 
laryngoscopy and tracheal intubation, surgical manipulation, 
procedures performed on the patient, and medication may 
also cause arrhythmia in the intraoperative period 2. These 
effects can be determined on 12-lead electrocardiograms 
(ECGs) by measuring P-wave dispersion (Pwd) and QT and 
corrected QT (QTc) intervals 1-6. Pwd is deﬁ ned as the diffe-
rence between the maximum and minimum P-wave duration 
in 12 leads of surface ECGs. Pwd is simple and non-invasive 
indicator of atrial arrhythmia such as atrial ﬂ utter or atrial 
ﬁ brillation 1,3-6. Increased Pwd is accepted as a predictor 
of postoperative atrial ﬁ brillation after coronary artery 
surgery 7,8. QT and QTc intervals are electrocardiographic 
indicators of ventricular repolarization. Prolongation of the 
QTc interval is associated with an increased risk of ventricular 
arrhythmias such as torsade de pointes 4-6.
Previous studies demonstrated that Pwd and QTc intervals 
might be extended in conditions such as diabetes mellitus 9,10, 
hypertension 11,12, malnutrition 5, subarachnoid hemorrhage 6, 
obesity 13,14 and metabolic syndrome 15. Also Pwd and QTc 
intervals extended after laryngoscopy and tracheal intu-
bation 1,2. For this reason, in patients with prolonged Pwd 
and QTc interval, choice of anesthetic and adjuvant drugs 
is important. 
The effects of esmolol 16, lidocaine 17 and fentanyl 4,18 
on QTc intervals during induction of anesthesia have been 
studied; however, little research has been done on their 
effects on Pwd duration during induction of anesthesia. In this 
study, we hypothesized that esmolol, lidocaine and fentanyl 
would affect Pwd. To test our hypothesis, we investigated 
the effect of esmolol, lidocaine and fentanyl on P-wave 
dispersion (Pwd), QT and corrected QT (QTc) durations and 
hemodynamic responses to endotracheal intubation during 
propofol induction.
Methods
This prospective randomized study was conducted in May-
November 2009 at Zonguldak Karaelmas University’s School 
of Medicine Research and Practice Hospital, Department of 
Anesthesiology and Reanimation after obtaining the appro-
val of the Hospital Ethics Board (date 05.22.2008, number: 
2008/07, President Dr. EY Sipahi) and patient consents.
Patients
After obtaining the approval from the hospital ethics com-
mittee, we enrolled 80 adult patients aged 18–60 years, with 
American Society of Anesthesiologists (ASA) Physical Status 
(PS) I and II, who were scheduled for elective non-cardiac 
surgery. Written informed consent was obtained from all 
participants. Age; ASA PS; serum sodium, potassium, calcium, 
chlorine and magnesium levels; and body mass index (BMI) 
were recorded. Thirty minutes prior to anesthesia induction, 
all patients were premedicated with intramuscular 0.07 mg/kg 
midazolam (Dormicum; Roche, Basel, Switzerland). In the 
operating theatre, a 20-gauge cannula was used for intrave-
nous access and 5-7 mL.kg-1 Ringer’s Lactate (Ringer Laktat; 
Polifarma, Istanbul, Turkey) infusion was started. 
Baseline arterial blood pressure, peripheral oxygen sa-
turation, and ECG records were obtained. All patients were 
subjected to standard 12-lead ECG using a Hewlett Packard 
PageWriter 300pi ECG device (Andover, MA, USA), and control 
ECGs were recorded at a paper speed of 50 mm.sec-1 with an 
amplitude of 1 mV/cm prior to anesthesia induction. After 
ECGs were recorded, patients were randomly divided into 
four groups using a random samples table.
anesthesia induction. Anesthesia was induced with intravenous propofol. ECGs for all patients 
were performed during the 1st and 3rd minutes of induction, 3 minutes after administration of 
muscle relaxant, and at 5 minutes and 10 minutes after intubation. Pwd and QT intervals were 
measured on all ECGs. QTc intervals were determined using the Bazett formula. Heart rate 
(HR) and mean arterial pressure (MAP) were recorded before and after induction of anesthesia, 
immediately after intubation, and 1, 3, 5, 7 and 10 minutes after intubation.
Results: Compared with control, HR signiﬁ cantly increased in Group C, Group L and Group F after 
intubation. However, in Group E, there was no signiﬁ cant difference in HR values between control 
and after intubation. Compared with control, MAP signiﬁ cantly increased in Group C and Group 
L after the intubation. However, in Group E and Group F, there was no signiﬁ cant difference in 
MAP values between control and after the intubation.  Compared with control, Pwd signiﬁ cantly 
increased in Group C after intubation. In Group L, Group F and Group E, there was no signiﬁ cant 
difference in Pwd values between control and after the intubation. Compared with control, QTc 
duration signiﬁ cantly increased in Group C and L after the intubation. In Group F and Group E, 
there was no signiﬁ cant difference in QTc durations between control and after the intubation.
Conclusion: We concluded that administration of esmolol before intubation prevents tachycardia 
and an increase in MAP, Pwd and QTc duration caused by laryngoscopy and tracheal intubation. 
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
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Exclusion criteria
Exclusion criteria were: pregnancy, anorexia (BMI < 18 kg.m-2), 
obesity (BMI > 30 kg.m-2), chronic liver and kidney diseases, 
electrolyte disorders, diabetes mellitus, hypothyroidism or 
hyperthyroidism, alcohol addiction, coronary artery disea-
se, Chagas disease, cardiomyopathy, arterial hypertension, 
atrial and/or ventricular hypertrophy on ECG, arrhythmia, 
cardiomegaly, valvular disease, cardiac insufﬁ ciency, and use 
of medication that led to extended QT intervals 1,5,6,15.
Anesthesia induction
In the control group (n = 20), patients previously received 
5 ml saline bolus, followed by a continuous infusion of 
saline. Anesthesia was induced by intravenous 2.5 mg.kg-1 
propofol (Propofol 1% Fresenius; Fresenius Kabi, Uppsala, 
Sweden) 1. 
In the lidocaine group (n = 20), patients previously re-
ceived a bolus dose of lidocaine 1.5 mg.kg-1, followed by a 
continuous infusion at 1.5 mg.kg-1.h-1. Next, anesthesia was 
induced intravenously with 2.5 mg.kg-1 propofol (Propofol 1% 
Fresenius; Fresenius Kabi, Uppsala, Sweden) 1,19. 
In the fentanyl group (n = 20), patients previously recei-
ved a bolus dose of fentanyl 2 μg.kg-1, followed by a continous 
infusion at 1 μg.kg-1.h-1. Next, anesthesia was induced intra-
venously with 2.5 mg.kg-1 propofol (Propofol 1% Fresenius; 
Fresenius Kabi, Uppsala, Sweden) 1,20. 
In the esmolol group (n = 20), patients previously re-
ceived a bolus dose of esmolol 0.5 mg.kg-1, followed by a 
continuous infusion at 100 μg.kg-1.h-1. Next, anesthesia was 
induced intravenously with 2.5 mg.kg-1 propofol (Propofol 1% 
Fresenius; Fresenius Kabi, Uppsala, Sweden). All of the groups 
have received 6 mg.kg-1.h-1 propofol infusion for anesthesia 
maintenance 1,21.  
All groups received 0.1 mg.kg-1 vecuronium for muscle 
relaxation at the 3rd minute of induction 1. Intubation was 
performed at 3 minutes after vecuronium administration. 
Throughout the entire study, a 60/40% oxygen/air mixtu-
re was used as carrier gas. Patients were ventilated with 
end-tidal CO2 at 35–40 mm Hg. We planned to administer 
intravenous 0.5 mg atropine (Atropin, Biofarma, Istanbul, 
Turkey) to patients with heart rate <50 beats.min-1, and 5 
mg ephedrine (Efedrin, Osel, Istanbul, Turkey) to those with 
mean arterial blood pressure < 30% of the control level for a 
minimum of 1 minute 1. 
ECGs were recorded during the 1st and 3rd minutes during 
anesthesia induction and 3 minutes after administration of 
muscle relaxant. Intubation was performed with a tube of 
appropriate size, and further ECGs were recorded at 5 and 
10 minutes, respectively. We recorded heart rate (HR), 
mean blood pressure, peripheral oxygen saturation (SpO2), 
and end-tidal carbon dioxide (ETCO2) during the 1
st and 3rd 
minute during anesthesia induction, 3 minutes after adminis-
tration of muscle relaxant, and 1, 2, 3, 4, 5 and 10 minutes 
after intubation. Surgery began after obtaining values at 10 
minutes post-intubation1.
Electrocardiography Analysis: Standard 12 derivation ECG 
recordings obtained from patients participating in the study 
with a paper speed of 50 mm.sec-1 and a deﬂ ection of 1 mm.mV-1 
were analyzed (Hewlett Packard®, Pagewriter 300pı). Heart 
rate was calculated using mean RR time 1,5,6,15. 
Analysis of P-wave dispersion: The beginning of P-wave 
was deﬁ ned as positive deﬂ ection from the isoelectric line, 
and the end as the point when the positive deﬂ ection retur-
ned to the isoelectric line. We excluded from the study any 
derivations where the beginning and end of P-waves were 
not obvious. Pwd was the difference between the longest 
and shortest P-wave durations 1,5,6,15. 
Analysis of QT, QTc duration: The QT interval was deﬁ -
ned as between the beginning of QRS complex and the point 
where T waves descend onto the TP isoelectric line. When 
a U wave interrupted the T wave before returning to baseli-
ne, the QT interval was measured to the nadir of the curve 
between the T and U waves 1,5,6. The corrected QT interval 
(QTc) was calculated using the Bazett formula; QTc (ms)=QT 
measured √RR (where RR is the RR interval) 1,5,6,15.
Subjects who had less than 9 derivations assessed on the 
ECG were excluded from the study. All ECG measurements 
were evaluated three times by two experts who were not 
aware of the group allocation 1,5,6,15.
Sample size calculation: Our primary endpoint was 
the P wave dispersion duration changes after intubation. 
Sample size estimation was based on the study performed 
by Acampa et al. 22. In order to detect a 20% change in Pwd 
duration (34 ± 6.1 msec control values in Acampa’s study 22), 
with an α error of 0.05 and a power of 90%, we calculated 
that sample size should be at least 17 patients per group. 
Estimating an approximate 20% dropout rate, we included 
20 patients in each group. The sample size estimation was 
performed using Power Calculator (http://www.dssresearch.
com/KnowledgeCenter/toolkitcalculators/samplesizecalcu-
lators.aspx). 
Statistical analysis: Statistical analyses were performed 
by using the Statistical Package for the Social Sciences (SPSS) 
version 16.0 for Windows (SPSS Inc., Chicago, IL, USA). 
Descriptive statistics included arithmetic means ± standard 
deviation (SD) for numerical data, and numbers and percen-
tages for categorical data. The Kolmogorov-Smirnov test was 
used to examine compatibility between measured variables 
and normal distribution. Mann-Whitney U test was used to 
compare the averages of data with continuous measures 
such as: serum sodium, potassium, calcium, chlorine and 
magnesium values; Pwd; QT and QTc durations; and HR, 
mean arterial pressure, ETCO2 and SpO2 values. The Wilcoxon 
Signed Ranks Test was used to compare intragroup repeated 
measures, and the χ2 test was used to compare data that 
denoted frequency, such as sex and ASA risk category. A p 
value < 0.05 after Bonferroni correction (p < 0.0083) was 
considered signiﬁ cant.
Results
Our subjects were allocated randomly into four groups. The 
groups were similar in terms of ASA risk category, age, sex, 
height, weight, and serum sodium, potassium, calcium, chlo-
rine and magnesium levels (p>0.0083) (Tables 1 and 2).
Heart rate changes 
There were no signiﬁ cant differences between the control HR 
values of the groups (p > 0.0083) (Figure 1). Mean HR changes 
between Group C and Groups L, F did not have signiﬁ cant 
difference (p > 0.0083) (Figure 1). When Groups E and C 
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Table 1  Demographic and anthropometric data.
Group C 
(n = 20)
Group L 
(n = 20)
Group F 
(n = 20)
Group E 
(n = 20)
Age (year) 33.75 ± 10.65 34.50 ± 9.97 35.25 ± 6.31 34.70 ± 6.23
Weight (kg) 75.40 ± 9.89 74.50 ± 9.54 75.85 ± 8.45 73.90 ± 10.34
Height (cm) 170.10 ± 8.57 169.55 ± 8.00 169.00 ± 6.04 170.90 ± 7.62
ASA (n, %)
I
II
17 (85%) 
3 (15%)
15 (75%) 
5 (25%)
16 (80%) 
4 (20%)
15 (75%) 
5 (25%)
Gender (n, %)
F
M
9 (45%) 
11 (55%)
9 (45%) 
11 (55%)
8 (40%) 
12 (60%)
8 (40%) 
12 (60%)
ASA: American Society of Anesthesiologists, F: Female, M: Male.
Table 2  Biochemical data of groups.
Normal values
Group C
 (n = 20)
Group L
 (n = 20)
Group F
 (n = 20)
Group E
 (n = 20)
Sodium (mmol.L-1) 136–145 143.10 ± 3.17 142.95 ± 2.39 143.05 ± 1.95 144.50 ± 1.79
Potassium (mmol.L-1) 3.5–5.5 4.43 ± 0.46 4.37 ± 0.42 4.56 ± 0.34 4.45 ± 0.32
Chlorine (mmol.L-1) 98–110 104.38 ± 3.18 105.30 ± 3.14 105.93 ± 2.89 106.03 ± 2.69
Calcium (mg.dL-1) 8.4–10.2 9.37 ± 0.51 9.23 ± 0.46 9.36 ± 0.42 9.52 ± 0.43
Magnesium (mg.dL-1) 1.3–2.7 2.14 ± 0.19 2.12 ± 0.17 2.06 ± 0.07 2.16 ± 0.17
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Figure 1  Changes in HR (beat.min-1).
P1 = Control, P2 = 1 minute after anesthesia induction; P3 = 3 minutes after anesthesia induction; P4 = 1 minute after 
administration of muscle relaxant; P5 = 3 minutes after administration of muscle relaxant; P6 = 1 minute after endotracheal 
intubation; P7 = 2 minutes after endotracheal intubation; P8 = 3 minutes after endotracheal intubation; P9 = 4 minutes after 
endotracheal intubation; P10 = 10 minutes after endotracheal intubation.
*: p < 0.0083 between Group C and Group E; †: p < 0.0083 between Group L and Group E;
‡: p < 0.0083 between control value in Group C; §: p < 0.0083 between control value in Group L; 
||: p < 0.0083 between control value in Group F; ¶: p < 0.0083 between control value in Group E.
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were compared in terms of HR values, Group E had lower HR 
values at 1, 2, 3 and 4 min after the intubation (p < 0.0083). 
In addition, Group E had lower HR values at 3, 4 and 5 min 
after intubation in comparison with group L (p < 0.0083) 
(Figure 1).  
Intra-group analysis of Group C has revealed that HR 
values, 1 and 3 min after the induction, 1, 2 and 3 min after 
the intubation were lower than the control HR value whereas 
1, 2 and 3 min after the intubation were higher than the 
control HR (p < 0.0083) (Figure 1).
HR values of Group L, at the 1st and 2nd min after intu-
bation were higher than the control value (p < 0.0083). HR 
values of Group F, at the 3rd min after the induction and 1st 
and 3rd after neuromuscular blockade were lower than the 
control value (p < 0.0083). HR values of Group E, at minu-
te 3 after the induction, 1 and 3 min after neuromuscular 
blockade and 10 min after intubation were lower than the 
control value (p < 0.0083) (Figure 1).
Mean blood pressure changes
Basal mean arterial blood pressure values did not differ 
signiﬁ cantly among the groups (p > 0.0083). Groups L and 
F did not have signiﬁ cant mean blood pressure changes in 
comparison with Group C (p < 0.0083) (Figure 2).
Mean arterial blood pressure values at 2, 3 and 4 min 
after the intubation were lower in Group E in comparison 
with Group C (p < 0.0083) (Figure 2). 
When the groups were compared between themselves, 
mean MAP values at 1 and 3 min after induction and neu-
romuscular blockade, 10 min after the intubation were 
lower than control MAP values, whereas the MAP value at 
1 min post-intubation was higher than the control value 
(p < 0.0083) (Figure 2).
In Group L, the control MAP value was signiﬁ cantly lower 
than the MAP values at 1 and 3 min after induction, 1 min 
after neuromuscular blockade administration, 5 and 10 min 
after the intubation (p < 0.0083). In Group F, control MAP 
value was signiﬁ cantly lower than the MAP values at 1 and 
3 min after induction and neuromuscular blockade adminis-
tration, 4, 5 and 10 min after the intubation (p < 0.0083). In 
Group E, control MAP value was signiﬁ cantly lower than the 
MAP values at 1 and 3 min after induction and neuromus-
cular blockade administration, 3, 4, 5 and 10 min after the 
intubation (p < 0.0083) (Figure 2).
Changes in SpO2 vs. ETCO2 
Intragroup and intergroup statistical analysis revealed 
no signiﬁ cant difference in relation to SpO2 and ETCO2 
(p > 0.0083).
Electrocardiographic changes  
All patients included in the study had sinus rhythm. No 
patients had atrioventricular or bundlebranch block, atrial 
or ventricular premature beat, tachyarrhythmia or bradyar-
rhythmia. When ECG records were analyzed, no signiﬁ cant 
difference was observed in terms of PR interval variations 
between and within the groups (p > 0.0083).
Changes in P wave dispersion 
Control ECG records were similar in terms of Pwd duration 
(p > 0.0083) (Figure 3). 
Pwd durations did not differ signiﬁ cantly between Group 
L, F and Group C at any measurement time (p > 0.0083). 
Measured Pwd values 5 and 10 min after the intubation in 
Group E were signiﬁ cantly lower than in Group C (p < 0.0083) 
(Figure 3).
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Figure 2  Changes in MAP (mm Hg).
P1 = Control, P2 = 1 minute after anesthesia induction; P3 = 3 minutes after anesthesia induction; P4 = 1 minute after 
administration of muscle relaxant; P5 = 3 minutes after administration of muscle relaxant; P6 = 1 minute after endotracheal 
intubation; P7 = 2 minutes after endotracheal intubation; P8 = 3 minutes after endotracheal intubation; P9 = 4 minutes after 
endotracheal intubation; P10 = 10 minutes after endotracheal intubation
*: p < 0.0083 between Group C and Group E; ‡: p < 0.0083 between control value in Group C; §: p < 0.0083 between control 
value in Group L; ||: p < 0.0083 between control value in Group F; ¶: p < 0.0083 between control value in Group E.
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Figure 3 - Changes in Pwd (msec).
T1 = Control, T2 = 1 minute after anesthesia induction; T3 = 3 minutes after anesthesia induction; T4 = 3 minutes after 
administration of muscle relaxant; T5 = 5 minutes after endotracheal intubation; T6 = 10 minutes after endotracheal 
intubation.
*: p < <0.0083 between Group C and Group E; ‡: p < 0.0083 between control value in Group C.
Figure 4 - Changes in QTc interval (msec).
T1 = Control, T2 = 1 minute after anesthesia induction; T3 = 3 minutes after anesthesia induction; T4 = 3 minutes after 
administration of muscle relaxant; T5 = 5 minutes after endotracheal intubation; T6 = 10 minutes after endotracheal 
intubation.
*: p < 0.0083 between Group C and Group E; **: p < 0.0083 between Group C and Group F; ‡: p < 0.0083 between control 
value in Group C; ||: p < 0.0083 between control value in Group F.
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When the groups were compared within themselves, 
while there were no signiﬁ cant difference in Pwd durations 
between the Pwd durations of control and all measurement 
times (p > 0.0083), Pwd durations at 5 and 10 minutes after 
the intubation were longer than control Pwd duration in 
Group C (p < 0.0083) (Figure 3).
Changes in QTc duration 
Groups were similar in terms of QTc duration at the control 
ECG records (p > 0.0083). Group L and Group C did not have 
signiﬁ cant difference in terms of QTc durations (p > 0.0083) 
(Figure 4).
QTc duration measured 1 min after the induction in Group 
F was signiﬁ cantly shorter than in Group C (p < 0.0083). 
Measured QTc durations 1 min after the induction and 5 min 
after the intubation in Group E were signiﬁ cantly shorter 
than in Group C (p < 0.0083) (Figure 4).
When the Groups were compared within themselves, 
QTc durations 1 min after the induction and 5 min after the 
intubation were signiﬁ cantly longer than the control value 
in Group C (p < 0.0083). Measured QTc duration 1 min after 
the induction in Group F was signiﬁ cantly shorter than the 
control QTc duration (p < 0.0083) (Figure 4).
Although Group L had shortening after the induction but 
prolongation in QTc durations after the intubation, QTc du-
rations at all measurement times did not differ signiﬁ cantly 
compared with the control value. (p > 0.0083). In the same 
manner, QTc durations at all measurement times did not 
differ signiﬁ cantly either when compared with the control 
value in Group E. (p > 0.0083).
Discussion
As a result of this prospective, randomised, double-blinded 
study on the effects of lidocaine, fentanyl and esmolol on the 
hemodynamic and electrocardiographic changes secondary to 
intubation, we have determined that esmolol had protective 
effects for tachycardia, increase of MAP and prolongation of 
Pwd, QTc durations. 
Important increases can occur in arterial blood pressu-
re, HR, and plasma catecholamine concentrations during 
laryngoscopy and endotracheal intubation 23. Increase in 
hemodynamic parameters may lead to myocardial ischemia, 
infarction, arrythmia and cerebral hemorrhage in patients 
with coronary heart disease, hypertension or cerebrovascular 
disease 24,25.
Prys-Roberts et al, has reported that reﬂ ex tachycardia 
and hypertension secondary to two different but conse-
cutive stimuli manifest themselves during laryngoscopy, 
increase with intubation and are rapidly resolved when the 
endotracheal tube is placed and laryngoscope is withdrawn; 
nonetheless, concominant arrhtymias continue26. 
Previous studies aiming to suppress hemodynamic res-
ponses accompanying laryngoscopy and tracheal intubation 
have deﬁ ned utilization of glossopharyngeal and superior 
laryngeal nerve blocks, topical or systemic lidocaine, deep 
levels of anesthesia with intravenous or inhalational anes-
thesia, opioids 27,28, magnesium sulphate, vasodilators 29, 
calcium channel 30, α or β adrenergic receptor blockers 27,29,31. 
On the other hand, studies comparing lidocaine, fentanyl and 
esmolol to suppress hemodynamic responses to intubation 
are limited.
In their study, Helfman et al. 27 had given 200 mg lidocai-
ne, 200 μg or 150 mg esmolol before anesthesia and induced 
it with 4-6 mg.kg-1 thiopenthal, 1-1.5 mg.kg-1 succinylcholine. 
They concluded that all three drugs were effective to block 
the increase in systolic blood pressure when compared to pla-
cebo. Additionally, researchers have reported that only the 
esmolol group had provided a stable and reliable protection 
against the increase in HR and systolic blood pressure.
Feng et al. 32 have compared the hemodynamic effects of 
2 mg.kg-1 lidocaine, 3 μg.kg-1 fentanyl or 2 mg.kg-1 esmolol 
administration before anesthesia induction with 5 mg.kg-1 
thiopenthal and 1.5 mg.kg-1 succinylcholine. They have con-
cluded that only esmolol has prevented the increase in both 
HR and blood pressure related to intubation. They reported 
that fentanyl was able to suppress increase in blood pressure 
but not the HR, whereas lidocaine was unable to suppress 
the response to laryngoscopy.
Ugur et al. 33, in their similar study, compared 1.5 mg.kg-1 
esmolol, 1 μg.kg-1 fentanyl and 1.5 mg.kg-1 lidocaine with 
respect to the hemodynamic responses to intubation. They 
concluded that esmolol administered 2 minutes before in-
tubation was the most effective agent in preventing HR and 
rate-pressure product increase.
In the current study, we determined that esmolol was 
the most efﬁ cient agent to depress the reﬂ ex response to 
laryngoscopy and tracheal intubation, in parallel with pre-
vious studies 27,32,33. 
Prolonged QT interval may cause arrhythmias such as 
polymorphic ventricular tachycardia or ventricular ﬁ brilation. 
As QT interval changes along with heart rate - extending with 
bradycardia and shortening with tachycardia - independently 
of other factors, we found corrected QT interval according 
to heart rate interval (QTc). Even though a QTc interval of 
440 milliseconds is considered prolonged, serious arrhythmias 
generally occur with a QTc interval of 600 milliseconds or 
longer 1,5,6,15,34. Prolonged QRS duration and increased disper-
sion of repolarization had been demonstrated to increase the 
risk of arrhythmic cardiac death in coronary artery disease 
patients 1,5,35. Therefore, prevention of the increase in HR, 
MAP, Pwd and QTc durations are important priorities for the 
induction of anesthesia in patients with prolonged QT, QTc, 
Pwd durations.
Previous studies demonstrated that QTc interval might 
be extended in conditions such as diabetes mellitus 10 
prehypertension 12, subarachnoid hemorrhage 6, malnutri-
tion 5, obesity 14 and metabolic syndrome 15. QTc intervals 
also extend after laryngoscopy and tracheal intubation 1,2. 
Therefore, in patients with prolonged QTc interval, the choi-
ce of anesthetic and adjuvant drugs is important. Previously, 
it was demonstrated that inhalation anesthetic agents such 
as desﬂ urane, sevoﬂ urane, isoﬂ urane, enﬂ urane or halo-
thane, extend the QTc interval duration 1,3,4,17. Despite the 
fact that etomidate and midazolam have no effects on the 
ventricle repolarization 3,17, they are not popular drugs for 
anesthesia induction. Propofol as an intravenous anesthetic 
agent is a popular choice for anesthesia induction in patients 
with prolonged QT, QTc, and Pwd interval, since it causes 
minimal prolongation of QT, QTc, and Pwd interval 1. In 
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the present study, we used propofol as an induction agent 
and choose a muscle relaxant with minimal cardiovascular 
side effects 1,16.
It is known that, laryngoscopy and tracheal intubation 
signiﬁ cantly increase the QTc duration 1,4,16-18. Previous studies 
demonstrated that, esmolol 16, lidocaine 17 and fentanyl 4,18 
attenuated QTc interval prolongation associated with trache-
al intubation. However, studies regarding the comparative 
effect of lidocaine, fentanyl and esmolol on QTc duration 
during laryngoscopy and tracheal intubation are limited 4,16-18. 
Although QTc intervals after the intubation and laryngoscopy 
did not present a signiﬁ cant difference between lidocaine, 
fentanyl and esmolol groups in the present study, when the 
results were compared to the control group, the most effec-
tive agent to prevent QTc prolongation after the intubation 
was found to be esmolol. 
It is known that lidocaine’s effect on cardiomyocytes 
is inadequate to prevent heart repolarization 36. Due to its 
anti-arrhythmic characteristics, lidocaine is used in the tre-
atment of heart rate disturbances of ventricular origin 37. In 
an earlier study researching the effect of lidocaine on QTc 
interval prolongation associated with tracheal intubation 17, 
researchers speculated that this effect of lidocaine could 
be associated with protective activation of the sympathetic 
system secondary to airway manipulation and, thus, inhibi-
tion of the prolonged repolarization 17. However, literature 
on this matter is confounding. Other studies demonstrated 
that lidocaine administration before intubation was unable 
to suppress the laryngoscopy and intubation-related sympa-
thetic activity 27,32,33,38. In addition, signiﬁ cant MAP increases 
were observed in lidocaine groups after intubation in Owczuk 
et al.’s 17 study, which raises the possibility of insufﬁ cient 
lidocaine efﬁ cacy in inhibiting sympathetic activation.
The previous studies on fentanyl for QTc interval are 
controversial 39,40. Wilton et al. 39 reported that fentanyl is 
associated with a decrease in the QTc interval in a patient 
with long QT syndrome. However another study on this to-
pic demonstrated QTc interval prolongation after fentanyl 
injection in patients undergoing coronary artery bypass graft 
operation 40.
It is known that beta-blockers, such as metoprolol, 
atenolol, reduce the cardiovascular response to sympathe-
tic stimulation and therefore, could prevent arrhythmias. 
Beta-blockers’ anti-sympathetic and anti-ischemic effect can 
cause QTc duration decrease 16. Erdil et al 16 and Korpinen et 
al. 41 reported that esmolol shortens the QTc interval after 
the laryngoscopy and intubation. However, other studies 42-45 
reported that esmolol prevented the prolongation of the QTc 
interval following the administration of intravenous anesthe-
tic agents, but not following laryngoscopy and intubation. 
On the other hand, the administration of esmolol may 
produce a clinically signiﬁ cant reduction in HR and MAP 46,47. 
These effects may cause hemodynamic depression, which 
may lead to increased myocardial ischemia in susceptible 
patients, especially in combination with anesthesia induction 
agents 41. However, we did not observe any hemodynamic 
hazard associated with esmolol. 
We believe the differences among the studies can be 
attributed to patients’ gender distribution, premedication 
status, and the use of different induction and adjuvant drugs 
in the anesthesia induction and maintenance periods.
Anesthetic substances may affect P wave dispersion 
(Pwd). The general anesthetic sevoﬂ urane has been reported 
to prolong Pwd, while desﬂ urane has no effect on it, and 
propofol shortens it 1,48,49. Pwd intervals also extend after 
laryngoscopy and tracheal intubation 1. However, to the best 
of our knowledge, there is no data about evaluating the 
effect of lidocaine, fentanyl and esmolol on prolonged Pwd 
due to laryngoscopy and tracheal intubation. 
We have determined that Pwd was prolonged in the con-
trol group following laryngoscopy and tracheal intubation. 
Although Pwd durations were prolonged after the intubation 
in lidocaine and fentanyl groups, when compared to control 
value Pwd durations did not increase signiﬁ cantly in either 
group. In contrary, Pwd durations after intubation were sig-
niﬁ cantly different between the control and esmolol groups. 
Therefore, only esmolol suppresses the prolongation in Pwd 
duration after intubation. Studies have demonstrated that 
β blocker agents like nebivolol 50,51, atenolol 51,52 and meto-
prolol 53 returned Pwd duration to normal values in the event 
that it is prolonged due to various reasons. However, most of 
these agents are not available in intravenous form in order to 
use at anesthesia induction, second, esmolol has the shortest 
elimination half-life among them making it a very suitable 
agent for procedures with a brief duration.
One of the limitations of our study is the manual calcu-
lation of Pwd on paper ECG. Also, we only searched Pwd, 
QT, and QTc changes at induction of anesthesia. Therefore, 
it might be better if future studies include the whole perio-
perative process with Holter monitoring, which would pro-
bably document any increased rate of atrial and ventricular 
arrhythmias due to its higher quality 1. 
We conclude that administration of esmolol before in-
tubation prevents tachycardia and an increase in MAP, Pwd 
and QTc durations caused by laryngoscopy and tracheal in-
tubation. Esmolol should be used for anesthesia induction in 
patients with a predisposition to preoperative arrhythmias, 
and in those whose Pwd and QTc durations are prolonged on 
their preoperative ECGs.
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